Leap therapeutics reports second quarter 2024 financial results

Cambridge, mass. , aug. 12, 2024 /prnewswire/ -- leap therapeutics, inc. (nasdaq:lptx), a biotechnology company focused on developing targeted and immuno-oncology therapeutics, today reported financial results for the second quarter ended june 30, 2024.

LPTX Ratings Summary

LPTX Quant Ranking